Cargando…
Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe
We assessed effectiveness and safety of concomitant chronic hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) and multidrug-resistant tuberculosis (MDR-TB). Of 322 MDR-TB patients (19.4% HCV), 30 were treated concomitantly (23.3% human immunodeficiency virus-positive). Overall,...
Autores principales: | Melikyan, Nara, Huerga, Helena, Atshemyan, Hakob, Kirakosyan, Ohanna, Sargsyants, Narina, Aydinyan, Tsovinar, Saribekyan, Nora, Khachatryan, Naira, Oganezova, Izabella, Falcao, Joana, Balkan, Suna, Hewison, Cathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896641/ https://www.ncbi.nlm.nih.gov/pubmed/33634203 http://dx.doi.org/10.1093/ofid/ofaa653 |
Ejemplares similares
-
High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study
por: Huerga, Helena, et al.
Publicado: (2019) -
Immunoglobulins concentration in HIV-infected patients' with viral hepatitis, candidiasis and herpes simplex viral infection
por: Sargsyants, Narina, et al.
Publicado: (2012) -
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study
por: Franke, Molly F., et al.
Publicado: (2021) -
Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology
por: Loewendorf, Andrea I., et al.
Publicado: (2016) -
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
por: Mbuagbaw, Lawrence, et al.
Publicado: (2019)